Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics Student Roster
Director
Larry M. Karnitz, Ph.D.
Review the focus areas, mentors and publications of current and former trainees in the Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic.
Appointee |
Mentor(s) |
Research focus |
Mayo Clinic publications |
Elizabeth K. Wiese |
Taro Hitosugi, Ph.D. |
The role of SDR9C7 in multiple myeloma |
Publications on PubMed |
Jordan M. Grainger |
Liewei Wang, M.D., Ph.D. |
Study of copy number amplification and chemo-response in triple negative breast cancer |
Publications on PubMed |
Erin M. Higgins |
Michael J. Ackerman, M.D., Ph.D. |
Elucidation of MRAS-mediated Noonan syndrome with cardiac hypertrophy |
Publications on PubMed |
Rebecca L. Kelly |
Larry M. Karnitz, Ph.D. |
Kinetic parameters for the metabolism of endoxifen |
Publications on PubMed |
Drew R. Neavin, Ph.D. |
Richard Weinshilboum, M.D. |
Metabolomics and single nucleotide polymorphism analyses to identify genetic components of response to SSRIs |
Publications on PubMed |
Sherri M. Biendarra-Tiegs |
Timothy J. Nelson, M.D., Ph.D. |
Patient-derived induced pluripotent stem cells to investigate cardiac drug toxicities |
Publications on PubMed |
Christopher Livia |
Atta Behfar, M.D., Ph.D. |
Mechanisms of reperfusion injury after myocardial ischemia and regenerative therapies to treat ischemia |
Publications on PubMed |
Katherine Minter Dykhouse |
Timothy J. Nelson, M.D., Ph.D. |
Modeling terminal differentiation of cardiomyocytes using the directed differentiation of human induced pluripotent stem cells to cardiomyocytes |
Publications on PubMed |
Stephanie L. Safgren, Ph.D., M.S. |
Martin E. Fernandez-Zapico, M.D. |
The chromatin remodeler SMARCA2 cooperates with GLI1 to regulate gene expression in pancreatic cancer cells |
Publications on PubMed |
Cordelia D. McGehee |
Scott H. Kaufmann, M.D., Ph.D.
Hu Li, Ph.D.
|
Identification of mechanisms of treatment resistance and responsiveness in ovarian cancer using systems pharmacology |
Publications on PubMed |
Carl T. Gustafson |
Michael J. Yaszemski, M.D., Ph.D. |
Wnt targets and therapeutic approaches in osteosarcoma |
Publications on PubMed |
Jamie D. Kapplinger, M.D., Ph.D. |
Michael J. Ackerman, M.D., Ph.D. |
Enhanced classification of non-synonymous single nucleotide variants in the SCN5A-encoded Nav1.5 cardiac sodium channel |
Publications on PubMed |
Alfreda D. Nelson |
Diana Gil Pages, Ph.D. |
Anti-TCR-CD3 fab homodimerization and the effects of ligand bivalency on T cell activation |
Publications on PubMed |
Review career outcomes for alumni of the T32 Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics (MPET) at Mayo Clinic:
Current career |
Former MPET T32 Ph.D. and M.D.-Ph.D. trainees* |
Research — academic faculty |
42% |
Research — academic staff |
17% |
Research — industry |
17% |
Research — government |
8% |
Teaching — faculty |
8% |
Medical practice |
0% |
Other industry or medical career |
8% |
*Trainees supported by the National Institute of General Medical Sciences-funded Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics (MPET) for the last 15 years. |